Hong Kong
· Delayed Price · Currency is HKD Regent Pacific Group Company Description
Regent Pacific Group Limited, an investment holding company, holds investments in the healthcare and life sciences sectors in Europe, the United States, and the Asia Pacific.
The company operates through Biopharma and Corporate Investment segments. It is involved in the research, development, manufacture, marketing, and sale of pharmaceutical products for the treatment and management of urological disorders; and development of artificial intelligence systems to track the rate of aging at the molecular, cellular, tissue, organ, system, physiological, and psychological levels.
The company also invests in listed and unlisted corporate entities. In addition, it provides management services.
The company was formerly known as Endurance RP Limited and changed its name to Regent Pacific Group Limited in July 2023.
Regent Pacific Group Limited was founded in 1991 and is headquartered in Central, Hong Kong.
| Country | Cayman Islands |
| Founded | 1991 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 17 |
| CEO | Jamie Alexander Gibson |
Contact Details
Address: Henley Building Central Hong Kong | |
| Phone | 852 2514 6111 |
| Website | regentpac.com |
Stock Details
| Ticker Symbol | 0575 |
| Exchange | Hong Kong Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| ISIN Number | KYG3042R1074 |
| SIC Code | 6799 |
Key Executives
| Name | Position |
|---|---|
| Jamie Alexander Gibson | Chief Executive Officer and Executive Director |
| Dr. Michael Grant Wyllie BSc, D.Sc., DSc | Co-Founder and Chief Scientific Officer |
| Yui Fui Wong | Chief Financial Officer |
| Paul Eric Jones BA, MBA | Investment Director |
| Mei Yan Lui | Company Secretary |
| Prof. John Michael Fitzpatrick FC Urol (SA), FRCS, FRCSGlas, FRCSI, MCh | Chairman of Clinical Scientific Advisory Board |